Intellipharmaceutics International Inc. (IPCIF)

IPCIF Income Statement

Financials in millions USD. Fiscal year is December - November.

Year	2022	2021	2020	2019	2018
Revenue	0.07	0.07	1.4	1.4	1.71
Revenue Growth (YoY)	0%	-95.31%	0%	-18.17%	-68.88%
Cost of Revenue	0	0.26	0.43	0.03	0.12
Gross Profit	0.07	-0.19	0.97	1.37	1.59
Selling, General & Admin	0.56	0.56	1.25	2.15	3.48
Research & Development	2.15	2.15	2.66	3.52	10.83
Other Operating Expenses	0	0.21	0.26	0.42	0.61
Operating Expenses	2.92	2.92	4.17	6.08	14.91
Operating Income	-2.85	-2.85	-4.17	-4.68	-13.33
Interest Income	0.29	0.55	0.97	0.01	0
Interest Expense	0.29	0.29	0.55	0.97	0.26
Other Expense / Income	0.04	0.29	1.51	-2.28	0.17
Pretax Income	-2.89	-2.89	-5.26	-3.36	-13.75
Income Tax	0.01	0.01	-0.11	0.03	-0.01
Net Income	-2.89	-2.89	-5.15	-3.39	-13.74
Shares Outstanding (Basic)	33	29	24	22	5
Shares Outstanding (Diluted)	33	29	24	22	5
Shares Change	12.45%	24.90%	9.18%	353.15%	53.55%
EPS (Basic)	-0.09	-0.10	-0.22	-0.16	-2.88
EPS (Diluted)	-0.09	-0.10	-0.22	-0.16	-2.88
Free Cash Flow	-1.39	-1.39	-2.47	0.11	-12.61
Free Cash Flow Per Share	-0.04	-0.05	-0.10	0.01	-2.65
Gross Margin	100.00%	-290.17%	69.25%	97.64%	92.71%
Operating Margin	-4336.82%	-4336.82%	-297.75%	-333.80%	-778.07%
Profit Margin	-4400.55%	-4400.55%	-367.11%	-241.95%	-802.16%
Free Cash Flow Margin	-2112.07%	-2112.07%	-175.90%	7.72%	-736.26%
EBITDA	-2.64	-2.64	-3.91	-1.76	-12.89
EBITDA Margin	-4023.32%	-4023.32%	-279.09%	-125.79%	-752.49%
Depreciation & Amortization	0.21	0.21	0.26	0.42	0.61
EBIT	-2.85	-2.85	-4.17	-2.18	-13.5
EBIT Margin	-4336.82%	-4336.82%	-297.75%	-155.43%	-788.26%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.